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Available online 23 October 2015AbstractOnly a few reports described the unusual imaging findings of necrosis and nodular regeneration in patients with acute liver failure. Herein, we
report on one case with acute liver failure secondary to drug-induced liver injury. This patient underwent abdominal CT scan twice with an
interval of 32 days. The second imaging findings were found to be significantly abnormal, and the multifocal areas were identified to be necrosis
and nodular regeneration by histopathologic evaluation. The dynamic changes of the imaging findings could reflect the characteristic progress of
acute liver failure.
© 2015 Beijing You’an Hospital affiliated to Capital Medical University. Production and hosting by Elsevier B.V. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Acute liver failure (ALF) is a condition in which rapid
deterioration of liver function results in encephalopathy and
coagulopathy in previously normal individuals [1e3]. Drug-
induced liver injury (DILI) is an important etiology of ALF,
although most of them tend to be self-limiting once the drug is
discontinued. As we know, the Multidetector CT (MDCT)
appearances in ALF resulting from DILI are extremely rare in
English literature. Here, we report the unusual MDCT findings
in a 27-year-old woman with ALF secondary to DILI.2. Case report
A 27-year-old woman was admitted to our hospital because
of a 4 weeks' history of unexplained abnormal liver function
tests. On physical examination, jaundice was identified, which
had been present for 3 weeks. When she was admitted after* Corresponding author.
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the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).one week, liver function tests were all disturbed. The
following values were obtained: alanine aminotransferase,
602.9 U/L (normal range, 5e40 U/L); aspartate aminotrans-
ferase, 692.0 U/L (normal range, 8e40 U/L); direct bilirubin
level, 148.1 mmol/L (normal range, 1.7e10 mmol/L); total
bilirubin, 272.5 mmol/L (normal range, 5e20 mmol/L); pro-
thrombin time, 18.2 s (normal range, 10e14 s); prothrombin
time activity percentage, 50.0% (normal range, 70e130%).
The patient has a definite history of nimesulide medication,
and serologic tests excluded the infection of HBV, HCV, HEV,
EBV, and CMV. So she was diagnosed as DILI and received
medical treatments as well as artificial liver support system
(ALSS) treatment twice. However, her condition continued to
deteriorate rapidly and developed encephalopathy 8 weeks
after the onset of jaundice. At day 72 after onset, she under-
went orthotopic liver transplantation.
The patient was performed abdominal CT scan for 2 times
at day 5 and 37 after admission respectively. The first exam-
ination showed a smooth surface and regular contour of the
liver. Precontrast CT image showed a homogeneous liver pa-
renchyma and high density change compared with that of
spleen (Fig. 1). Postcontrast CT image demonstrated a ho-
mogeneous enhancement of liver parenchyma in the three
phases (Fig. 2). Three-dimensional volume rendering. Production and hosting by Elsevier B.V. This is an open access article under
Fig. 1. A 27-year-old woman with acute liver failure secondary to drug-
induced liver injury. The first examination showed a smooth surface and
regular contour of the liver. Precontrast CT image showed a homogeneous
liver parenchyma and high density change compared with that of spleen.
Fig. 3. A 27-year-old woman with acute liver failure secondary to drug-
induced liver injury. The second precontrast abdominal CT image shows a
heterogeneous liver parenchyma with hyperattenuation or hypoattenuation
areas mainly in the lateral segment of the left lobe and anterior segment of the
right lobe. The relatively hyperattenuation areas (corresponding to regions of
regeneration at pathologic examination) appear lobulated contours and are
located predominantly in the liver periphery, while the hypoattenuation areas
(corresponding to regions of necrosis) are located primarily in the liver center.
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1072.113 cm3.
On the second, precontrast abdominal CT scan showed a
heterogeneous liver parenchyma with hypoattenuation or
hyperattenuation areas mainly in the lateral segment of the left
lobe and anterior segment of the right lobe. The relatively
hyperattenuation areas appeared lobulated contours and were
located in the liver periphery predominantly, while the hypo-
attenuation areas were located primarily in the liver center
(Fig. 3). After contrast-enhanced, these relatively hyper-
attenuation areas were significantly enhanced in arterial phase
and appeared as isoattenuation or slightly hypoattenuation
regions in portal-venous phase and equilibrium phase
compared with the surrounding liver parenchyma. These
relatively hypoattenuation areas presented mildly arterial
enhancement and obviously enhancement in portal-venousFig. 2. A 27-year-old woman with acute liver failure secondary to drug-
induced liver injury. The first postcontrast CT image demonstrated a homo-
geneous enhancement of liver parenchyma in the three phase.phase, which showed flip-flop phenomenon compared with
precontrast CT images (Figs. 4 and 5). The liver volume was
approximately 933.513 cm3, which was markedly smaller than
that on the first examination. At this time, the liver function
tests showed that alanine aminotransferase was 82.6 U/L
(normal range, 5e40 U/L); aspartate aminotransferase was
53.2 U/L (normal range, 8e40 U/L); direct bilirubin level,
58.1 mmol/L (normal range, 1.7e10 mmol/L); total bilirubin,
108.3 mmol/L (normal range, 5e20 mmol/L); prothrombin
time, no agglutination (normal range, 10e14 s); prothrombinFig. 4. A 27-year-old woman with acute liver failure secondary to drug-
induced liver injury. On the second postcontrast abdominal CT image, the
relatively hyperattenuation areas (corresponding to regions of regeneration at
pathologic examination) reveals significantly enhancement in arterial phase.
And the relatively hypoattenuation areas (corresponding to regions of necrosis)
presents mildly arterial enhancement.
Fig. 5. A 27-year-old woman with acute liver failure secondary to drug-
induced liver injury. On the second postcontrast abdominal CT image, the
relatively hyperattenuation areas appears as isoattenuation or slightly hypo-
attenuation regions in portal-venous phase compare with the surrounding liver
parenchyma. The relatively hypoattenuation areas displays obviously
enhancement in portal-venous phase, which shows flip-flop phenomenon
compare with precontrast CT image.
Fig. 7. A 27-year-old woman with acute liver failure secondary to drug-
induced liver injury. Histopathologic evaluation of the hyperattenuation
areas on unenhanced CT reveals nodular regeneration of hepatocytes after
bridging necrosis in the liver parenchyma. (H and E).
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ammonia, 113 mg/dL (normal range, 12e66 mg/dL).
Pathologic examinations after liver transplantation showed
that multiple confluent nodular regeneration in the lateral and
anterior segments, and hepatic necrosis was throughout the
rest of the liver (Fig. 6). Histopathologic evaluation of the
hyperattenuation areas on unenhanced CT revealed nodular
regeneration of hepatocytes after bridging necrosis in the liver
parenchyma (Fig. 7). The remaining areas, which were rela-
tively high enhancement relative to the regenerating paren-
chyma on enhanced CT, were consistent with the necrosis
areas on pathologic examination. In which there were sub-
massive necrosis of liver lobule, destruction of reticulinFig. 6. A 27-year-old woman with acute liver failure secondary to drug-
induced liver injury. Sectioned liver transplantation specimen shows there
are multiple confluent nodular regeneration in the lateral and anterior seg-
ments, and hepatic necrosis are throughout the rest of the liver.structure, diffuse liver parenchymal collapse, proliferation of
bile duct, and bile staining of lobular periphery.
3. Discussion
Drug-induced liver injury is caused by some drugs and/or
its metabolites, which can occur in previously healthy in-
dividuals or patients with serious diseases. At least 1000 kinds
of drugs have been reported to be associated with DILI [4].
Non-steroidal anti-inflammatory drugs are one of the most
common causes of DILI [5]. The clinical manifestations of
DILI are similar to viral hepatitis, including hepatocyte ne-
crosis, cholestasis, chronic hepatitis, cirrhosis and so on.
Although most of patients with nimesulide-induced DILI tend
to be self-limiting after the cessation of drug administration,
there are a few cases will develop acute liver failure [5].
In ALF, massive necrosis of hepatocytes is present. If the
patients survive, liver cell regeneration with disorganized
nodules of regenerating hepatocytes and fibrosis eventually
develop [6,7]. The necrotic areas contract in size, sub-
massive necrosis of liver lobule, destruction of reticular
structure, diffuse liver parenchymal collapse, proliferation of
bile duct, and bile staining are seen within these areas. After
several weeks, nodular regeneration and fibrosis is developed
and firm nodules are surrounded by soft areas of necrosis
[6,7]. The process of pathological changes is the basis of
imaging findings. Previously reported CT findings of fulmi-
nant hepatitis include decreased liver size (massive necrosis),
diffuse or localized (solitary or multiple) areas of hypo-
attenuation (corresponding to areas of necrosis) in the liver,
dilatation of the portal vein, narrow or non-depicted hepatic
veins, and focal or diffuse areas of hyperattenuation (corre-
sponding to areas of regeneration) during recovery [8]. The
mechanism of this enhancement on CT may depend on in-
flammatory cell infiltration, increased arterial supply, slow
transit rate of blood, an extensive interstitial space, and
149N. He et al. / Radiology of Infectious Diseases 2 (2015) 146e149changes in the diffusion rate between the interstitial space and
the vascular space results in postnecrotic regions enhance-
ment [2,9].
Itai et al. [9] have identified postnecrotic scars showing
hypoattenuation on precontrast CT image and isoattenuation
or hyperattenuation relative to the liver on postcontrast CT
image. Murakami et al. [10] have reported imaging findings
with pathologic correlations in three patients with fulminant
hepatitis. They displayed areas of liver necrosis as hypo-
attenuation before administration of contrast material and
isoattenuation or hyperattenuation compared with areas of
liver regeneration on enhanced CT images. Conversely, these
authors showed areas of nodular liver regeneration as hyper-
attenuation on unenhanced and hypoattenuation on enhanced
imaging. They also found liver cell necrosis predominantly in
the central region and nodular regeneration in the periphery of
the liver [2,10].
In our case, the first CT examination showed no obvious
abnormalities in the liver with significantly abnormal liver
function tests, but the liver function was still in compensated.
As the disease continued to worsen, the patient received the
second abdominal CT scan 32 days later. It showed that the
multifocal areas appeared as hyperattenuation on unenhanced
images and was significantly enhanced in arterial phase, while
presented as isoattenuation or slightly hypoattenuation regions
in portal-venous phase and equilibrium phase compared with
the surrounding liver parenchyma. These areas were identified
to be regenerating regions by histopathologic evaluation. The
remaining liver parenchyma was relatively hypoattenuation on
precontrast CT scan and appeared to be obviously high
enhanced in portal-venous phase on postcontrast CT relative to
the regenerating parenchyma. These areas were identified as
necrosis. The CT findings of our case are similar to that re-
ported by Murakami et al. [10]. On the same day, the liver
function tests suggested the liver was in the stage of irre-
versible decompensation, which were consistent with the im-
aging findings on CT scan.
4. Conclusion
In summary, only a few reports described the unusual im-
aging findings of necrosis and nodular regeneration in patients
with ALF [9,10]. Our patient underwent abdominal CT scan
twice with an interval of 32 days. The dynamic changes of the
imaging findings could reflect the characteristic progress of
ALF. Focal regeneration surrounded by areas of necrosis
might be mistaken for malignant neoplasms on CT scan. Thus,
for patients with ALF, we should consider the possibility of
nodular regeneration if the hyperattenuation areas on precon-
trast CT were significantly enhanced in arterial phase and
appeared as isoattenuation or slightly hypoattenuation regions
in portal-venous phase and equilibrium phase compared with
the surrounding liver parenchyma. So, it is important for ra-
diologists and clinicians to realize these unusual imaging
findings and avoid a misdiagnosis as malignancy.Competing interests
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